- Advertisement -
Monday, 30 November 2020

CHARITY TODAY AWARDS

Experts hope an anti-sickness drug will treat hallucinations in Parkinson’s

- Advertisement -

PARKINSON’S UK is funding a new research study into a possible treatment for hallucinations in Parkinson’s.

Ondansetron is an anti-sickness medication, usually used for people having cancer treatment. This trial will explore whether it can effectively treat visual hallucinations in people with Parkinson’s.

The Trial of Ondansetron as a Parkinson’s Hallucination Treatment (TOPHAT) will run in partnership with UCL. The £1m phase 2 clinical trial will test the drug against a placebo (a dummy treatment) in 216 people with Parkinson’s who experience hallucinations.

Parkinson’s UK has been working with UCL and research volunteers to adapt to this project during the pandemic rapidly. To minimise risk, and help participants to feel safe, researchers will conduct the majority of the study via video or telephone consultations.

If this research shows that ondansetron is safe and effective, it could be made available to people with Parkinson’s on the NHS without the need for further studies. This could mean a vital new treatment in just a few years.

Hallucinations in Parkinson’s

There are currently 145,000 people living with Parkinson’s in the UK, and 75% are likely to experience visual hallucinations at some point. Either because of their condition or as a side effect to medications to treat other symptoms of Parkinson’s. Hallucinations are when people see, hear or feel things that aren’t really there.

Hallucinations can have a big impact on the quality of life, as well as being frightening for people with Parkinson’s and their families. There are currently no specific treatments approved in the UK for people with Parkinson’s who experience this distressing symptom.

This trial comes at a crucial time. In a recent survey conducted by Parkinson’s UK and researchers at the University of Lancaster, 1 in 10 respondents reported that hallucinations had worsened during the COVID-19 pandemic.

Michelle Ellis, 54, from Ashby-de-la-Zouch, Leicestershire, was diagnosed with Parkinson’s in 2012. She was just 46 and experienced her first hallucination 4 years later.

Michelle says:

“My hallucinations have started to increase in the past few months, and I want them to settle down. I tend to dwell on them when I am having a bad day with my Parkinson’s symptoms. It’s very important to have a drug that focuses on treating hallucinations on their own.”

Dr Arthur Roach, Director of Research at Parkinson’s UK, says:

“It’s vital we find better treatments for people with Parkinson’s who have seen their hallucinations worsen at home and ondansetron offers much hope for them and their families.

“If successful, positive results from the trial could see this drug, which is already used in the NHS, quickly repurposed to become an available treatment in Parkinson’s.”

Suzanne Reeves, Lead Researcher and Professor of Old Age Psychiatry and Psychopharmacology at UCL, says:

“Visual hallucinations pose a particular challenge in Parkinson’s as the very treatments for motor symptoms in Parkinson’s can also trigger and worsen this distressing symptom. Finding treatments for hallucinations that are both effective and safe is an area of great unmet need.”

Sign up to receive full FREE access to charity news and special sector offers.

We don’t spam! Read our privacy policy for more info.

- Advertisement -
- Advertisement -

Stay Connected

1,381FansLike
1,834FollowersFollow
30,217FollowersFollow
1,200SubscribersSubscribe

Must Read

WaterAid brings showbiz stars straight to homes with virtual Christmas during #UKCharityWeek

WATERAID is hosting a star-studded virtual ‘Christmas Get Together’ during #UKCharityWeek on Tuesday 8 December from 6.30pm, bringing seasonal songs, festive readings and special...

Iconic football commentator and bowel cancer survivor, John Motson, calls for more support into bowel research

WORLD-renowned football commentator, John Motson, has this week given his backing to new charity, Bowel Research UK, as part of a bid to drive...

Employment News

Four new Trustees join Dame Kelly Holmes Trust Board

DAME Kelly Holmes Trust has announced the appointment of four additional Trustees who joined the Board on 20th November 2020. Catherine Baker, Helen Donovan, Martin...

Eric Dier announced as ambassador for Sported

TOTTENHAM Hotspur and England defender Eric Dier has today been announced as an ambassador for Sported, the UK's largest network of community groups supporting...

National Animal Welfare Trust appoints director of operations

RESCUE and rehoming charity National Animal Welfare Trust (NAWT) has appointed Andrew Gillon as director of operations. Andrew brings nearly two decades of experience in the...

Related News

New chair of national youth charity OnSide Youth Zones

YOUTH charity OnSide Youth Zones has appointed tech entrepreneur Charles Mindenhall as Chair of its board of Trustees. Since it was founded in 2008, OnSide...

Four new Trustees join Dame Kelly Holmes Trust Board

DAME Kelly Holmes Trust has announced the appointment of four additional Trustees who joined the Board on 20th November 2020. Catherine Baker, Helen Donovan, Martin...

Shop this Christmas using the Kindred extension and raise money for charity

KINDRED are the social enterprise mixing up the way we fundraise for charity. Recently launched, they have plans to be the largest mechanism for...

Clear Sky: Using Play and Creative Arts to address Childhood Trauma post COVID-19

‘Making a positive contribution’ 2020 has been a year of change for many of us. Everyone has had to make adjustments to normal life to...

Eric Dier announced as ambassador for Sported

TOTTENHAM Hotspur and England defender Eric Dier has today been announced as an ambassador for Sported, the UK's largest network of community groups supporting...
- Advertisement -
X